Preprint Review Version 1 This version is not peer-reviewed

G-Quadruplex targeting ligands: A hope and a new horizon in Cancer Therapeutics

Version 1 : Received: 15 November 2018 / Approved: 16 November 2018 / Online: 16 November 2018 (11:34:24 CET)

How to cite: Banerjee, N.; Panda, S.; Chatterjee, S. G-Quadruplex targeting ligands: A hope and a new horizon in Cancer Therapeutics. Preprints 2018, 2018110409 (doi: 10.20944/preprints201811.0409.v1). Banerjee, N.; Panda, S.; Chatterjee, S. G-Quadruplex targeting ligands: A hope and a new horizon in Cancer Therapeutics. Preprints 2018, 2018110409 (doi: 10.20944/preprints201811.0409.v1).

Abstract

G-quadruplex, a unique secondary structure in nucleic acids found throughout human genome elicited widespread interest in the field of therapeutic research. Being present in key regulatory regions of oncogenes, G-quadruplex structure regulates transcription, translation, splicing, telomere stability etc. Changes in its structure and stability lead to differential expression of oncogenes causing cancer. Thus, targeting G-Quadruplex structures with small molecules/ other biologics has shown elevated research interest. Covering previous reports, in this review we try to enlighten the facts on the structural diversity in G-quadruplex ligands aiming to provide newer insights to design first-in-class drugs for the next generation cancer treatment.

Subject Areas

G quadruplex, Oncogene, ligand, cancer

Readers' Comments and Ratings (0)

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.